UFP Technologies (UFPT) FY Conference June 11, 2025 07:55 AM ET Speaker0 Part advisers. Thank you guys for joining us bright and early. presenting company of the day is UFP Technologies. With us here from the company today, we have Jeff Bailey, chairman, CEO, and Ron Lattay, CFO. UFP is a client of three part advisors for a number of years. If anyone would like a follow-up call, anything, just reach out to me directly. Happy to help set that up. And with that, I'll just turn it over to Jeff. Speaker1 Thank ...

Twine Shareholders Investing into Steakholder at $7 per ADS; More than 200% Premium Above Current ADS Price Strategic Acquisition Would Position Combined Company As Pioneering Force Across Food Tech and Textile Industries, Building Digital Printing and Dyeing Technology Powerhouse Since its foundation, Twine has installed more than 30 systems at leading brands, dye houses and textile fulfillers Rehovot, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (Nasdaq: STKH), a leading innovator in a ...

The initial order, received June 6, 2025, calls for 1000 one-gram live resin vape cartridges, which HYTN will manufacture in strict compliance with GMP standards and export under its Drug Establishment Licence (DEL) to the United Kingdom, pending export permit approval, with shipment scheduled to occur before the import permit expiry date of September 6, 2025. This underscores HYTN's commitment to quality, safety, and consistency in its pharmaceutical-grade cannabis offerings and highlights its capability t ...

Jiangsu Zhongtian Technology Co., Ltd. Environmental, Social and Governance ESG Report 2024 Connecting Wonderful Life with Optic-Electric Network Add: No.88 Qixin Road, NETDA, Nantong, Jiangsu, P.R. China, 226009 Tel: +86 513 8010 0986 Email: sales@zttgroup.com Website: http://www.zttgroup.com CONTENT Chairman's Speech 01 04 06 Appendices 08 From Commitment To Action: Putting people ?rst: Sustainable Governance social responsibility and inclusive for a sustainable future Performance (SDGs) (GRI Standards) S ...

Core Viewpoint - MaxCyte and Ori Biotech have formed a strategic collaboration to enhance the efficiency, scalability, and productivity of cell therapy manufacturing by integrating their respective platforms, ExPERT™ and IRO® [1][4]. Group 1: Collaboration Details - The collaboration combines MaxCyte's ExPERT™ platform, known for its efficient transfection capabilities, with Ori's IRO platform, which automates cell therapy manufacturing [2][3]. - The initial evaluation will focus on optimizing the yield and manufacturing timelines of MaxCyte-engineered primary T cells using CD19 CAR expression via CRISPR knock-in [2][3]. Group 2: Technological Integration - MaxCyte's technology provides flexibility and efficiency in transfecting cells at a clinical scale, integrating well with various processes in cell therapy workflows [3]. - Ori's IRO platform enhances cell culture efficiency through automated fluid handling and customizable mixing, contributing to improved scalability [3]. Group 3: Leadership Insights - MaxCyte's CEO expressed excitement about the collaboration, emphasizing the commitment to improving manufacturing processes and accelerating the availability of cell therapies [4]. - Ori's CEO highlighted the partnership as a demonstration of their dedication to providing scalable solutions that address challenges in cell and gene therapy manufacturing [4]. Group 4: Industry Impact - The collaboration aims to enable therapy developers to adopt integrated solutions, thereby accelerating the transition from research to commercialization and increasing patient access to next-generation treatments [4].

Fabrinet (FN) FY 2025 Conference June 10, 2025 11:00 AM ET Speaker0 Hi, everybody. Welcome. Good morning, good afternoon, depending on where you are. Welcome to the Rosenblatt Age of AI conference, to our June session. I am Mike Genovese, the cloud and communications equipment infrastructure analyst. I'm super happy that you're all joining us today and very pleased to have the management team from Fabrinet. We have Seamus, we have Saba, and we have Garo, CEO, CFO, and head of investor relations. Great to se ...

Key Takeaways CRS shares skyrocketed 140% y/y and touched a 52-week high of $252.63 before closing at $248.74. Record Q3 operating income and strong Aerospace demand drive CRS's bullish fiscal 2025 outlook. CRS raised the FY25 operating income guidance to $520-$527M, projecting 48% growth over fiscal 2024.Carpenter Technology Corporation (CRS) shares scaled a new 52-week high of $252.63 on Friday before closing the session lower at $248.74.CRS has a market capitalization of $12.4 billion. The company’s sh ...

"Flex is proud to collaborate with MIT on this important initiative to shape the future of manufacturing." Post this As a founding member of the INM Industry Consortium, Flex will work closely with MIT researchers, educators, and fellow industry leaders to support cutting-edge projects that apply AI, machine automation, and new system-level approaches to manufacturing. "Flex is proud to collaborate with MIT on this important initiative to shape the future of manufacturing," said Cameron Carr, chief strateg ...

Latham Group (SWIM) FY Conference June 05, 2025 09:40 AM ET Speaker0 Morning, everyone. Thanks for being here. This is the SWIM presentation, Latham. Before we begin, I need to remind you that a complete list of disclosures and conflicts of interest is available on our website. I'm Ryan Merkel. I cover building products at William Blair. With us today is Oliver Glow, CFO of Latham. For those that don't know the company, Latham is a leading producer of inground residential pools specializing in fiberglass po ...

Investor Presentation William Blair Growth Stock Conference June 2025 Forward-looking Statements Certain statements in this presentation constitute forward-looking statements under federal securities laws. These forward-looking statements reflect our views with respect to future events and financial performance as of the date of this presentation or otherwise specified herein. Actual events and results may differ materially from those contemplated by such forward-looking statements due to risks and other fa ...